Estimate Of Lives Lost Due To Delay In Antiretroviral Drug Use For HIV/AIDS In South Africa

More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/).

More: continued here

Filed under: Women's Health / OBGYN on October 27th, 2008